LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 8 of total 8

Search options

  1. Article: Success and Limitation of Equine Influenza Vaccination: The First Incursion in a Decade of a Florida Clade 1 Equine Influenza Virus that Shakes Protection Despite High Vaccine Coverage.

    Fougerolle, Stéphanie / Fortier, Christine / Legrand, Loïc / Jourdan, Marion / Marcillaud-Pitel, Christel / Pronost, Stéphane / Paillot, Romain

    Vaccines

    2019  Volume 7, Issue 4

    Abstract: Every year, several epizooties of equine influenza (EI) are reported worldwide. However, no EI case has been identified in France between 2015 and late 2018, despite an effective field surveillance of the pathogen and the disease. Vaccination against ... ...

    Abstract Every year, several epizooties of equine influenza (EI) are reported worldwide. However, no EI case has been identified in France between 2015 and late 2018, despite an effective field surveillance of the pathogen and the disease. Vaccination against equine influenza virus (EIV) remains to this day one of the most effective methods to prevent or limit EI outbreaks and the lack of detection of the pathogen could be linked to vaccination coverage. The aim of this study was to evaluate EI immunity and vaccine coverage in France through a large-scale serological study. A total of 3004 archived surplus serums from French horses of all ages, breeds and sexes were selected from four different geographical regions and categories (i.e., sanitary check prior to exportation, sale, breeding protocol or illness diagnosis). EIV-specific antibody response was measured by single radial hemolysis (SRH) and an EIV-nucleoprotein (NP) ELISA (used as a DIVA test). Overall immunity coverage against EIV infection (i.e., titers induced by vaccination and/or natural infection above the clinical protection threshold) reached 87.6%. The EIV NP ELISA results showed that 83% of SRH positive serum samples from young horses (≤3 years old) did not have NP antibodies, which indicates that the SRH antibody response was likely induced by EI vaccination alone (the HA recombinant canarypoxvirus-based EI vaccine is mostly used in France) and supports the absence of EIV circulation in French horse populations between 2015 and late 2018, as reported by the French equine infectious diseases surveillance network (RESPE). Results from this study confirm a strong EI immunity in a large cohort of French horses, which provides an explanation to the lack of clinical EI in France in recent years and highlights the success of vaccination against this disease. However, such EI protection has been challenged since late 2018 by the incursion in the EU of a Florida Clade 1 sub-lineage EIV (undetected in France since 2009), which is also reported here.
    Language English
    Publishing date 2019-11-02
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2703319-3
    ISSN 2076-393X
    ISSN 2076-393X
    DOI 10.3390/vaccines7040174
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Florida clade 1 equine influenza virus in France.

    Paillot, Romain / Pitel, Pierre-Hugues / Pronost, Stéphane / Legrand, Loïc / Fougerolle, Stéphanie / Jourdan, Marion / Marcillaud-Pitel, Christel

    The Veterinary record

    2019  Volume 184, Issue 3, Page(s) 101

    MeSH term(s) Animals ; Disease Outbreaks/veterinary ; France/epidemiology ; Horse Diseases/epidemiology ; Horse Diseases/prevention & control ; Horse Diseases/virology ; Horses ; Influenza A Virus, H3N8 Subtype/isolation & purification ; Influenza Vaccines/administration & dosage ; Orthomyxoviridae Infections/epidemiology ; Orthomyxoviridae Infections/prevention & control ; Orthomyxoviridae Infections/veterinary ; Orthomyxoviridae Infections/virology ; Vaccination/statistics & numerical data ; Vaccination/veterinary
    Chemical Substances Influenza Vaccines
    Language English
    Publishing date 2019-01-17
    Publishing country England
    Document type Letter
    ZDB-ID 390015-0
    ISSN 2042-7670 ; 0042-4900
    ISSN (online) 2042-7670
    ISSN 0042-4900
    DOI 10.1136/vr.l1203
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Genetic evolution of equine influenza virus strains (H3N8) isolated in France from 1967 to 2015 and the implications of several potential pathogenic factors.

    Fougerolle, Stéphanie / Legrand, Loïc / Lecouturier, Fanny / Sailleau, Corinne / Paillot, Romain / Hans, Aymeric / Pronost, Stéphane

    Virology

    2017  Volume 505, Page(s) 210–217

    Abstract: Equine influenza virus (EIV) is a major respiratory pathogen of horses despite the availability of equine influenza vaccines. This study aimed to determine genetic evolution of EIV strains in France between 1967 to present. A whole genome comparative ... ...

    Abstract Equine influenza virus (EIV) is a major respiratory pathogen of horses despite the availability of equine influenza vaccines. This study aimed to determine genetic evolution of EIV strains in France between 1967 to present. A whole genome comparative analysis was also conducted on recent French strains in order to identify potential factors of pathogenicity. Comparison of French EIV sequences with vaccine and worldwide epidemic strains revealed amino acid substitutions in both haemagglutinin (HA) and neuraminidase, especially within the antigenic sites and/or close to receptor binding sites (HA). Amino acid substitutions were also identified in other genes, mainly the polymerase complex proteins and PB1-F2. Viruses belonging to Eurasian and American lineages have circulated until 2003 and Florida sub-lineage Clade 2 strains predominates since 2005. The last French strain (2015) displayed several specificities in HA suggesting the occurrence of antigenic drift with presence of pathogenic markers in the PA and PB1-F2 genes.
    MeSH term(s) Amino Acid Sequence ; Amino Acid Substitution/genetics ; Animals ; Binding Sites/genetics ; Evolution, Molecular ; France/epidemiology ; Genome/genetics ; Hemagglutinin Glycoproteins, Influenza Virus/genetics ; Horse Diseases/epidemiology ; Horse Diseases/virology ; Horses/virology ; Influenza A Virus, H3N8 Subtype/genetics ; Influenza A Virus, H3N8 Subtype/isolation & purification ; Neuraminidase/genetics ; Orthomyxoviridae Infections/epidemiology ; Orthomyxoviridae Infections/veterinary ; Orthomyxoviridae Infections/virology ; Sequence Alignment
    Chemical Substances Hemagglutinin Glycoproteins, Influenza Virus ; Neuraminidase (EC 3.2.1.18)
    Language English
    Publishing date 2017-05
    Publishing country United States
    Document type Journal Article
    ZDB-ID 200425-2
    ISSN 1096-0341 ; 0042-6822
    ISSN (online) 1096-0341
    ISSN 0042-6822
    DOI 10.1016/j.virol.2017.02.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Impact of Mixed Equine Influenza Vaccination on Correlate of Protection in Horses.

    Dilai, Mohamed / Piro, Mohammed / El Harrak, Mehdi / Fougerolle, Stéphanie / Dehhaoui, Mohammed / Dikrallah, Asmaa / Legrand, Loïc / Paillot, Romain / Fassi Fihri, Ouafaa

    Vaccines

    2018  Volume 6, Issue 4

    Abstract: To evaluate the humoral immune response to mixed Equine Influenza vaccination, a common practice in the field, an experimental study was carried out on 42 unvaccinated thoroughbred weanling foals divided into six groups of seven. Three groups were ... ...

    Abstract To evaluate the humoral immune response to mixed Equine Influenza vaccination, a common practice in the field, an experimental study was carried out on 42 unvaccinated thoroughbred weanling foals divided into six groups of seven. Three groups were vaccinated using a non-mixed protocol (Equilis
    Language English
    Publishing date 2018-10-04
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2703319-3
    ISSN 2076-393X
    ISSN 2076-393X
    DOI 10.3390/vaccines6040071
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Influential factors inducing suboptimal humoral response to vector-based influenza immunisation in Thoroughbred foals

    Fougerolle, Stéphanie / Dion Garrett / Ilhan Birand / Loïc Legrand / Marc Foursin / Pierre Bayssat / Richard J. Newton / Romain Paillot / Stéphane Pronost / Xavier D’Ablon

    Vaccine. 2016 July 19, v. 34, no. 33

    2016  

    Abstract: Numerous equine influenza (EI) epizooties are reported worldwide. EI vaccination is the most efficient methods of prevention. However, not all horses develop protective immunity after immunisation, increasing the risk of infection and transmission.This ... ...

    Abstract Numerous equine influenza (EI) epizooties are reported worldwide. EI vaccination is the most efficient methods of prevention. However, not all horses develop protective immunity after immunisation, increasing the risk of infection and transmission.This field study aimed to understand the poor response to primary EI vaccination.The EI antibody response was measured in 174 Thoroughbred foals set in 3 stud farms (SF#1 to SF#3) over a 2years period. All foals were immunised with a commercial recombinant canarypox-based EI vaccine. Sera were tested by single radial haemolysis against the A/equine/Jouars/4/06 EIV strain (H3N8) at the time of the first vaccination (V1), 2weeks and 3months after the second immunisation (V2), 2days and 3months after the third immunisation (V3).The frequency of poor-responders (no detectable antibody titres) was surprisingly elevated after V2 (56.8%), increased to 81.7% at V2+3months and reached 98.6% at V3. The frequency of poor-responder was still 19.2%, 3months after V3. Two independent influential factors were identified. The short (V2+2weeks) and mid-term (V2+3months, V3+3months) antibody levels were positively correlated to the age at V1 (p-value=0.003, 0.031 and 0.0038, respectively). Presence of maternally-derived antibodies (MDA) at V1 was negatively correlated with antibody levels after V3 only (p-value=0.0056). Given that SF#1 antibody response was below clinical protective levels at all-time points studied, the annual boost immunisation (V4) was brought forward by 7.0±1.1months. V1 was delayed by 7weeks the following year, which significantly increased short- and mid-term antibody titres (p-value=9.9e−07 and 2.31e−07, respectively).The age and MDA at first immunisation with the canarypox-based IE vaccine play an independent role in the establishment of antibody levels. This study also highlights the benefit provided by serological surveillance to evaluate herd immunity and to implement corrective management/vaccination measures.
    Keywords antibodies ; antibody formation ; equine influenza ; farms ; foals ; hemolysis ; herd immunity ; humoral immunity ; Influenza A virus ; monitoring ; risk ; Thoroughbred ; vaccination ; vaccines
    Language English
    Dates of publication 2016-0719
    Size p. 3787-3795.
    Publishing place Elsevier Ltd
    Document type Article
    ZDB-ID 605674-x
    ISSN 1873-2518 ; 0264-410X
    ISSN (online) 1873-2518
    ISSN 0264-410X
    DOI 10.1016/j.vaccine.2016.05.068
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  6. Article ; Online: Serological investigation of racehorse vaccination against equine influenza in Morocco.

    Dilai, Mohamed / Piro, Mohammed / Fougerolle, Stéphanie / El Harrak, Mehdi / Mahir, Wissal / El Mourid, Rachida / Legrand, Loïc / Paillot, Romain / Fassi Fihri, Ouafaa

    Veterinary microbiology

    2018  Volume 223, Page(s) 153–159

    Abstract: In order to evaluate the vaccination status against equine influenza (EI) in Moroccan racehorses, a serological investigation was carried out on 509 racehorses using three serological tests: an Enzyme-Linked Immunosorbent Assay (ELISA), the ... ...

    Abstract In order to evaluate the vaccination status against equine influenza (EI) in Moroccan racehorses, a serological investigation was carried out on 509 racehorses using three serological tests: an Enzyme-Linked Immunosorbent Assay (ELISA), the Hemagglutination Inhibition (HI) test and the Single Radial Haemolysis (SRH) assay. The serological analysis showed 56% of seropositivity by ELISA, 67% by HI and 89.4% by SRH (with 69.9% above the clinical protection threshold). Using the Kappa test, the SRH and HI assays showed a strong agreement, the SRH and ELISA assays had a moderate agreement and the HI and ELISA assays showed a poor agreement. Seropositivity was positively correlated with the age of horses and the number of immunisation received. EI vaccines used during the last immunisation before the study had a weak influence on the serological status. This effect was observed when the vaccines Calvenza and Fluvac Innovator® were used, with 94.1% and 100% of seropositivity when measured by HI, and with 100% and 94.7% exceeding the clinical protection threshold when measured by SRH, respectively. No effect was found when other EI vaccines, including Prequenza-Te® (67% coverage (342/509) and Proteqflu-Te® (22% coverage (114/509) were used; with 64% and 67.5% seropositivity (HI) and with 66.4% and 72.8% above the clinical threshold (SRH), respectively. The location and the time since last vaccination have no influence on the serological result. Overall, levels of protective antibody against EI in Moroccan racehorses remain a concern despite mandatory vaccination.
    MeSH term(s) Animals ; Antibodies, Viral/analysis ; Enzyme-Linked Immunosorbent Assay/veterinary ; Hemagglutination Inhibition Tests/veterinary ; Horse Diseases/prevention & control ; Horse Diseases/virology ; Horses ; Influenza A virus/immunology ; Influenza Vaccines/immunology ; Morocco ; Orthomyxoviridae Infections/prevention & control ; Orthomyxoviridae Infections/veterinary ; Orthomyxoviridae Infections/virology ; Vaccination/veterinary
    Chemical Substances Antibodies, Viral ; Influenza Vaccines
    Language English
    Publishing date 2018-08-11
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 753154-0
    ISSN 1873-2542 ; 0378-1135
    ISSN (online) 1873-2542
    ISSN 0378-1135
    DOI 10.1016/j.vetmic.2018.08.014
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Refinement of the equine influenza model in the natural host: A meta-analysis to determine the benefits of individual nebulisation for experimental infection and vaccine evaluation in the face of decreased strain pathogenicity.

    Garrett, Dion / Montesso, Fernando / Fougerolle, Stéphanie / Lopez-Alvarez, Maria R / Birand, Ilhan / De Bock, Manuelle / Huang, Chengjin M / Legrand, Loïc / Pronost, Stéphane / Paillot, Romain

    Veterinary microbiology

    2017  Volume 211, Page(s) 150–159

    Abstract: Equine Influenza (EI) is an important respiratory disease of horses caused by H3N8 equine influenza viruses (EIV). Vaccination is a key strategy to prevent or control this disease. However, EIV undergoes continuous antigenic drift and whilst numerous EI ... ...

    Abstract Equine Influenza (EI) is an important respiratory disease of horses caused by H3N8 equine influenza viruses (EIV). Vaccination is a key strategy to prevent or control this disease. However, EIV undergoes continuous antigenic drift and whilst numerous EI vaccines are commercially available worldwide, an accurate evaluation of their efficacy is frequently required through clinical trials conducted in the natural host. Room nebulisation is one of the chosen methods to challenge horses during EI vaccine studies. A potential decreased pathogenicity observed with recent Florida Clade 2 (FC2) EIV isolates have increased the heterogeneity of the clinical response and virus shedding measured after infection by room nebulisation, which reduced the statistical power of studies. Our objectives were to compare clinical and virological parameters following experimental infection with several different EIV strains and to confirm that individual nebulisation is a model refinement that prevents an increase of the number of animals per group. This study is a retrospective comparison and meta-analysis of clinical and virological results collected from 9 independent EIV infection studies in the natural host. Naïve Welsh mountain ponies were experimentally infected by room or individual nebulisation with FC2 EIV strains, including A/equine/Richmond/1/07 (R/07), A/equine/East Renfrewshire/11 (ER/11), A/equine/Cambremer/1/2012 (C/12) and A/equine/Northamptonshire/1/13 (N/1/13). The retrospective meta-analysis confirmed a decreased pathogenicity of the EIV ER/11 and C/12 strains when compared with R/07. Experimental infection by individual nebulisation improved the clinical and virological parameters induced by recent FC2 strains, when compared with conventional room nebulisation. In conclusion, individual nebulisation offers a better control of the challenge dose administered and a greater homogeneity of the response measured in control animals. This in turn, helps maintain the number of animals per group to the minimum necessary required to obtain meaningful results in vaccine efficacy studies, which adheres to the 3Rs (Replacement, Reduction and Refinement) principles.
    MeSH term(s) Animals ; Horse Diseases/prevention & control ; Horse Diseases/virology ; Horses ; Influenza A Virus, H3N8 Subtype/immunology ; Influenza A Virus, H3N8 Subtype/pathogenicity ; Orthomyxoviridae Infections/prevention & control ; Orthomyxoviridae Infections/veterinary ; Orthomyxoviridae Infections/virology ; Vaccination/veterinary ; Virus Shedding
    Language English
    Publishing date 2017-11
    Publishing country Netherlands
    Document type Journal Article ; Meta-Analysis
    ZDB-ID 753154-0
    ISSN 1873-2542 ; 0378-1135
    ISSN (online) 1873-2542
    ISSN 0378-1135
    DOI 10.1016/j.vetmic.2017.10.010
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Influential factors inducing suboptimal humoral response to vector-based influenza immunisation in Thoroughbred foals.

    Fougerolle, Stéphanie / Legrand, Loïc / Garrett, Dion / Birand, Ilhan / Foursin, Marc / D'Ablon, Xavier / Bayssat, Pierre / Newton, Richard J / Pronost, Stéphane / Paillot, Romain

    Vaccine

    2016  Volume 34, Issue 33, Page(s) 3787–3795

    Abstract: Context: Numerous equine influenza (EI) epizooties are reported worldwide. EI vaccination is the most efficient methods of prevention. However, not all horses develop protective immunity after immunisation, increasing the risk of infection and ... ...

    Abstract Context: Numerous equine influenza (EI) epizooties are reported worldwide. EI vaccination is the most efficient methods of prevention. However, not all horses develop protective immunity after immunisation, increasing the risk of infection and transmission.
    Objectives: This field study aimed to understand the poor response to primary EI vaccination.
    Study design: The EI antibody response was measured in 174 Thoroughbred foals set in 3 stud farms (SF#1 to SF#3) over a 2years period. All foals were immunised with a commercial recombinant canarypox-based EI vaccine. Sera were tested by single radial haemolysis against the A/equine/Jouars/4/06 EIV strain (H3N8) at the time of the first vaccination (V1), 2weeks and 3months after the second immunisation (V2), 2days and 3months after the third immunisation (V3).
    Results: The frequency of poor-responders (no detectable antibody titres) was surprisingly elevated after V2 (56.8%), increased to 81.7% at V2+3months and reached 98.6% at V3. The frequency of poor-responder was still 19.2%, 3months after V3. Two independent influential factors were identified. The short (V2+2weeks) and mid-term (V2+3months, V3+3months) antibody levels were positively correlated to the age at V1 (p-value=0.003, 0.031 and 0.0038, respectively). Presence of maternally-derived antibodies (MDA) at V1 was negatively correlated with antibody levels after V3 only (p-value=0.0056). Given that SF#1 antibody response was below clinical protective levels at all-time points studied, the annual boost immunisation (V4) was brought forward by 7.0±1.1months. V1 was delayed by 7weeks the following year, which significantly increased short- and mid-term antibody titres (p-value=9.9e-07 and 2.31e-07, respectively).
    Conclusion: The age and MDA at first immunisation with the canarypox-based IE vaccine play an independent role in the establishment of antibody levels. This study also highlights the benefit provided by serological surveillance to evaluate herd immunity and to implement corrective management/vaccination measures.
    MeSH term(s) Age Factors ; Animals ; Antibodies, Viral/blood ; Antibody Formation ; Canarypox virus ; Horse Diseases/prevention & control ; Horse Diseases/virology ; Horses/immunology ; Immunity, Humoral ; Immunity, Maternally-Acquired ; Influenza A Virus, H3N8 Subtype ; Influenza Vaccines/immunology ; Orthomyxoviridae Infections/prevention & control ; Orthomyxoviridae Infections/veterinary
    Chemical Substances Antibodies, Viral ; Influenza Vaccines
    Language English
    Publishing date 2016-07-19
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 605674-x
    ISSN 1873-2518 ; 0264-410X
    ISSN (online) 1873-2518
    ISSN 0264-410X
    DOI 10.1016/j.vaccine.2016.05.068
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top